APA (7th ed.) Citation

N, K., G, K., & M, V. (2025). Metabolic Dysfunction Associated-Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Embrace All Facets of the Disease. Current cardiology reports, 27(1), 19. https://doi.org/10.1007/s11886-024-02181-9

Chicago Style (17th ed.) Citation

N, Katsiki, Kolovou G, and Vrablik M. "Metabolic Dysfunction Associated-Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Embrace All Facets of the Disease." Current Cardiology Reports 27, no. 1 (2025): 19. https://doi.org/10.1007/s11886-024-02181-9.

MLA (9th ed.) Citation

N, Katsiki, et al. "Metabolic Dysfunction Associated-Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Embrace All Facets of the Disease." Current Cardiology Reports, vol. 27, no. 1, 2025, p. 19, https://doi.org/10.1007/s11886-024-02181-9.